ECSP982396A - COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN - Google Patents
COMPOSITIONS CONTAINING TETRAHYDROLYPSTATINInfo
- Publication number
- ECSP982396A ECSP982396A ECSP982396A ECSP982396A EC SP982396 A ECSP982396 A EC SP982396A EC SP982396 A ECSP982396 A EC SP982396A EC SP982396 A ECSP982396 A EC SP982396A
- Authority
- EC
- Ecuador
- Prior art keywords
- tetrahydrolypstatin
- compositions containing
- product
- compositions
- particles
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- AHLBNYSZXLDEJQ-UHFFFAOYSA-N N-formyl-L-leucylester Natural products CCCCCCCCCCCC(OC(=O)C(CC(C)C)NC=O)CC1OC(=O)C1CCCCCC AHLBNYSZXLDEJQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El invento se refiere a un producto conteniendo tetrahidrolipstatina como ingrediente activo y excipientes farmacéuticamente aceptables, caracterizado porque está en forma de partículas como un diámetro de 0.25 a 2mm; y preparaciones o composiciones farmacéuticas para administración oral que contiene dicho producto.The invention relates to a product containing tetrahydrolipstatin as an active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0.25 to 2mm; and pharmaceutical preparations or compositions for oral administration containing said product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982396 ECSP982396A (en) | 1998-02-04 | 1998-02-04 | COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982396 ECSP982396A (en) | 1998-02-04 | 1998-02-04 | COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982396A true ECSP982396A (en) | 1999-01-12 |
Family
ID=42043319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982396 ECSP982396A (en) | 1998-02-04 | 1998-02-04 | COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982396A (en) |
-
1998
- 1998-02-04 EC ECSP982396 patent/ECSP982396A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2156028T3 (en) | Compositions containing tetrahydrolipstatin | |
| BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
| GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
| IL138767A0 (en) | Anticancer compositions | |
| TW355683B (en) | Composition containing micronized nebivolol | |
| EE9900288A (en) | Use of an Oral Pharmaceutical Composition for the manufacture of a medicament for the treatment of erectile dysfunction in men | |
| ATE333265T1 (en) | RAPIDLY DISSOLVING SOLID DOSAGE FORMS FOR ORAL APPLICATION | |
| HRP20020088B1 (en) | LEVODOPA / CARBIDOPA / ENTACAPON PHARMACEUTICAL PREPARATION | |
| MX2007015480A (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption. | |
| DE69923336D1 (en) | ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| IT1263840B (en) | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES | |
| BR0112847A (en) | Use of a solid dosage form | |
| MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
| MXPA03005221A (en) | Pharmaceutical dronedarone composition for parenteral administration. | |
| AR032614A1 (en) | CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE | |
| SE0001916D0 (en) | Novel formulation | |
| HRP20020258B1 (en) | PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS CONTRACEPTIVE | |
| MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
| GEP20043377B (en) | Pharmaceutical Complex | |
| BE2016C017I2 (en) | ||
| ECSP982396A (en) | COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN | |
| MXPA02006034A (en) | Oral mucosal dosage forms of apomorphine. | |
| ITMI20020872A1 (en) | HYPERPHORINE DERIVATIVES THEIR USE AND FORMULATIONS CONTAINING THEM | |
| ATE301469T1 (en) | PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE |